Tag:
TLN-232
Latest Headlines
Latest Headlines
Dispute forces Thallion to halt patient enrollment
Engaged in a squabble with an unnamed licensor, Thallion Pharmaceuticals has called a halt to patient enrollment for a mid-stage study of its experimental therapy for metastatic melanoma. Thallion
